Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2017 | 04-2017 | 01-2017 | 10-2016 | 07-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,715 | 2,789 | 3,968 | 4,139 | 5,269 |
| Receivables | 297 | 185 | 142 | 146 | 263 |
| Inventories | 273 | 348 | 340 | 348 | 350 |
| TOTAL | $2,459 | $3,476 | $4,639 | $4,964 | $6,142 |
| Non-Current Assets | |||||
| PPE Net | 548 | 574 | 568 | 495 | 440 |
| Intangibles | 822 | 858 | 901 | 943 | 980 |
| TOTAL | $1,370 | $1,432 | $1,469 | $1,438 | $1,420 |
| Total Assets | $3,829 | $4,908 | $6,108 | $6,402 | $7,562 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 426 | 574 | 424 | 654 | 479 |
| Accrued Expenses | 249 | 194 | 245 | 193 | 216 |
| Other current liabilities | 1,853 | 1,665 | 1,523 | 1,995 | 1,841 |
| TOTAL | $2,528 | $2,433 | $2,192 | $2,842 | $2,536 |
| Non-Current Liabilities | |||||
| TOTAL | $11 | $12 | $13 | $3 | $3 |
| Total Liabilities | $2,539 | $2,445 | $2,205 | $2,845 | $2,539 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,932 | 62,707 | 62,601 | 62,200 | 64,824 |
| Common Shares | 631 | 628 | 627 | 649 | 649 |
| Retained earnings | -109,482 | -107,636 | -105,898 | -104,962 | -103,219 |
| TOTAL | $1,290 | $2,463 | $3,903 | $3,557 | $5,023 |
| Total Liabilities And Equity | $3,829 | $4,908 | $6,108 | $6,402 | $7,562 |